Back to Search Start Over

Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor

Authors :
O. De Cobelli
Francesco Perri
Riccardo Schiavina
Francesco Cantiello
P. De Placido
Vincenzo Mirone
S. M. Di Stasi
Carlo Buonerba
Riccardo Autorino
Giuseppe Morgia
Michele Battaglia
Rocco Damiano
Guru Sonpavde
Gennaro Musi
Vincenzo Ieluzzi
Giuseppe Lucarelli
Gian Maria Busetto
Mihai Dorin Vartolomei
A Gabriele
A.R. Abu Farhan
Pierluigi Bove
Giovanna Russo
S. Perdonà
Rodolfo Hurle
Amelia Cimmino
Giorgio Guazzoni
F. Del Giudice
G. Di Lorenzo
Estevão Lima
Luca Scafuri
Nicolae Crisan
Gilberto L. Almeida
Daniela Terracciano
Dario Bruzzese
Marco Borghesi
Paolo Verze
Matteo Ferro
S.F. Shariat
Ferro M, Di Lorenzo G, Vartolomei MD, Bruzzese D, Cantiello F, Lucarelli G, Musi G, Di Stasi S, Hurle R, Guazzoni G, Busetto GM, Gabriele A, Del Giudice F, Damiano R, Perri F, Perdona S, Verze P, Borghesi M, Schiavina R, Almeida GL, Bove P, Lima E, Autorino R, Crisan N, Farhan ARA, Battaglia M, Russo GI, Ieluzzi V, Morgia G, De Placido P, Terracciano D, Cimmino A, Scafuri L, Mirone V, De Cobelli O, Shariat S, Sonpavde G, Buonerba C
Ferro, M.
Di Lorenzo, G.
Vartolomei, M. D.
Bruzzese, D.
Cantiello, F.
Lucarelli, G.
Musi, G.
Di Stasi, S.
Hurle, R.
Guazzoni, G.
Busetto, G. M.
Gabriele, A.
Del Giudice, F.
Damiano, R.
Perri, F.
Perdona, S.
Verze, P.
Borghesi, M.
Schiavina, R.
Almeida, G. L.
Bove, P.
Lima, E.
Autorino, R.
Crisan, N.
Farhan, A. R. A.
Battaglia, M.
Russo, G. I.
Ieluzzi, V.
Morgia, G.
De Placido, P.
Terracciano, D.
Cimmino, A.
Scafuri, L.
Mirone, V.
De Cobelli, O.
Shariat, S.
Sonpavde, G.
Buonerba, C.
Publication Year :
2020

Abstract

BACKGROUND: Basophils, eosinophils and monocytes may be involved in BCG-induced immune responses and be associated with outcomes of bladder cancer patients receiving intravesical BCG. Our objective was to explore the association of baseline counts of basophils, eosinophils and monocytes with outcomes of patients with high-grade T1 bladder cancer receiving a standard course of intravesical BCG. METHODS: We retrospectively reviewed medical records of patients with primary T1 HG/G3 bladder cancer. After re-TURBT, patients were treated with a 6-week course of intravesical BCG induction followed by intravesical BCG every week for 3 weeks given at 3, 6, 12, 18, 24, 30 and 36 months from initiation of therapy The analysis of potential risk factors for recurrence, muscle invasion and cancer-specific and overall survival was performed using univariable Cox regression models. Those factors that presented, at univariate analysis, an association with the event at a liberal p

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....d9c2ec7d7245501e058b7b71bfd11bc9